Search for Clinical Trial Results

Sponsored By

Acute Erythroid Leukemia - 171 Studies Found

Status Study
Completed Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia
  • Adult Acute Erythroid Leukemia (M6)
  • Adult Acute Megakaryoblasti
    Date: 2013-11-25
    Interventions:
    • Drug: liposomal cytarabine-daunorubicin CPX-351

Completed Study Name: Vorinostat in Treating Patients With Acute Myeloid Leukemia
Condition:
  • Adult Acute Erythroid Leukemia (M6)
  • Adult Acute Megakaryoblasti
    Date: 2006-03-21
    Interventions:
    • Drug: vorinostat Given orally

Completed Study Name: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leuk
    Date: 2014-05-20
    Interventions:
    • Drug: choline magnesium trisalicylate

Terminated Study Name: AML Therapy With Irradiated Allogeneic Cells
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leuk
    Date: 2014-04-02
    Interventions:
    • Drug: fludarabine phosphate Gi
Active, not recruiting Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition:
  • Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
  • Adult Acute Monoblastic Leukemia
    Date: 2014-01-28
    Interventions:
    • Drug: MEK inhibitor MEK162 Giv
Terminated Study Name: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leuk
    Date: 2013-11-25
    Interventions: Drug: ixazomib Given PO Other Names:
Active, not recruiting Study Name: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leuk
    Date: 2013-07-17
    Interventions:
    • Drug: lenalidomide Given PO
Active, not recruiting Study Name: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leuk
    Date: 2013-06-04
    Interventions:
    • Other: antitumor drug screening assay

Active, not recruiting Study Name: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leuk
    Date: 2013-05-06
    Interventions:
    • Drug: metformin hydrochloride

<<< Previous | Next >>>